Provided by Tiger Trade Technology Pte. Ltd.

Adial Pharmaceuticals

6.22
+0.31505.34%
Post-market: 6.03-0.1850-2.98%19:30 EDT
Volume:81.99K
Turnover:493.98K
Market Cap:16.32M
PE:-0.35
High:6.41
Open:5.95
Low:5.74
Close:5.90
52wk High:10.75
52wk Low:1.31
Shares:2.63M
Float Shares:2.55M
Volume Ratio:0.92
T/O Rate:3.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.7100
EPS(LYR):-11.9306
ROE:-2011.66%
ROA:-40.08%
PB:-0.43
PE(LYR):-0.52

Loading ...

Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge

TIPRANKS
·
Aug 22

Adial Pharmaceuticals Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Minimum

Reuters
·
Aug 22

U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies

Reuters
·
Aug 17

U.S. Stocks on the MOVE - KBR, Vista Energy, Fulcrum Therapeutics

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 EPS $(11.25)

Benzinga Earnings
·
Aug 17

Adial Pharmaceuticals Falls After Quarterly Loss Widens

Reuters
·
Aug 17

Adial Pharmaceuticals Posts Bigger-than-Expected Q2 Net Loss, Hurt by Acquisition Charges

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 Net Income USD -52 Million

THOMSON REUTERS
·
Aug 17

Press Release: Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Dow Jones
·
Aug 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 17

Adial Pharma Faces Governance Risks and Major Dilution as 2026 Shareholder Vote Looms on Preferred Conversions and Warrants

TIPRANKS
·
Aug 16

Adial Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Adial Q2 Net Loss Widens to $51.99 Million from Year-Ago Quarter

Reuters
·
Aug 15

Adial Pharmaceuticals Plans Major Leadership and Board Transition

TIPRANKS
·
Aug 14

Adial Pharmaceuticals - as of Aug 10, Anticipates Termination of CEO Cary Claiborne After 2026 Annual Meeting

Reuters
·
Aug 14

Adial Pharmaceuticals - Anticipates Board Changes and Legacy Member Resignations After Stockholder Approval - SEC Filing

THOMSON REUTERS
·
Aug 14

Adial Pharmaceuticals - Anticipates Termination of CFO Vinay Shah After 2026 Annual Meeting - SEC Filing

THOMSON REUTERS
·
Aug 14

Adial Pharmaceuticals CEO Cary Claiborne Set to Depart After Sept. 17 Annual Meeting; CDO Matthew Davidson Slated to Succeed

Reuters
·
Aug 14

Adial Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 11

Adial Pharmaceuticals Inc Expected to Post a Loss of $1.03 a Share - Earnings Preview

Reuters
·
Aug 08